Skip to content

Nevirapine paediatric dosing: adult tablets can be split, Thai study reports

Efavirenz and rifampicin: UK doctors caution on higher EFV doses in Africans (corrected)

Aging HIV population cause for concern

IAS: Rifampin TB treatment does not reduce response to NNRTIs, South Africans report

IAS: New tablet formulation of Kaletra is on its way, manufacturer says

Nevirapine lingers for two weeks after mums give birth

Efavirenz reduces blood statin concentrations

XIV International HIV Drug Resistance Workshop: Clinical response

Duration of ddI treatment and dose risk factors for CD4 loss in patients taking ddI/tenofovir